Life-prolonging drug for advanced ovarian cancer gets go-ahead in England

4 juin 2026 | Anna Bawden Health and social affairs correspondent
Elahere is first new drug for chemotherapy-resistant ovarian cancer to be approved by NHS for 20 years Hundreds of women with hard-to-treat ovarian cancer can now be offered a new life-prolonging treatment, after NHS England approved its introduction. It is the first new drug for resistant (…)
 Site référencé:  The Guardian (South&CentralAsia)

The Guardian (South&CentralAsia) 

Civilians flee Mogadishu as Somali troops and opposition-allied militias trade fire
4/06/2026
Bracketology : predict a path to World Cup victory
4/06/2026
‘To them a power line is a line of trees’ : Costa Rica moves to protect howler monkeys from electrocution
4/06/2026
Rebekah Vardy gets a bad rap – but she’s my queen of the one-liner
4/06/2026
Who would England be likely to play if they reach the World Cup final ?
4/06/2026
Leftwing US commentator calls decision to ban him from UK ‘Kafkaesque’
4/06/2026